HONG KONG, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) – uSmart Securities Limited ("uSMART Securities/the Company") is pleased to announce the official opening of its ninth and tenth physical service centres in Tai Wai and Tuen Mun. Within just one year, uSMART Securities has expanded its Hong Kong service network to 12 physical service centres, surpassing industry benchmarks and actively implementing its "Online x Offline" (O2O) community finance strategy. This expansion solidifies its position as the “No.1 Hong Kong Funded Fintech Brokerage^” and further enhances brand influence.Promoting Accessible Community Financial ServicesThe Tuen Mun branch held a simple yet meaningful opening ceremony today, marking the official commencement of services and a new chapter in the Company's development. Mr. Neo Lee, Executive Director of uSMART Securities, stated: "The opening of the Tai Wai and Tuen Mun branches represent a crucial strategic move in our commitment to local communities and advancing community-oriented services. We focus not only on network coverage but also on connecting with the community, upholding our 'customer-centric' philosophy. By bridging the gap with residents, we are advancing toward our goal of 'seamless coverage across Hong Kong'."(From left to right: Business Development Manager of uSMART Securities, Executive Director of Research Department of uSMART Securities, Executive Director of uSMART Securities, Marketing Director of uSMART Securities and Business Development Director of uSMART Securities)(From left to right: Business Development Manager of uSMART Securities, Executive Director of Research Department of uSMART Securities, Executive Director of uSMART Securities, Marketing Director of uSMART Securities and Business Development Director of uSMART Securities)Comprehensive Coverage Across Hong Kong 18 DistrictsAiming to accelerate the goal of becoming "the Fintech brokerage with the most service centres in Hong Kong," uSMART Securities will open branches in core areas, Kai Tak and Mong Kok in the second quarter. The company is also actively exploring pop-up stores in shopping malls and participating in various exhibition booths. Through multi-channel engagement with customers across different districts, the company aims to refine its regional presence, enabling citizens across all 18 districts to easily access professional and personalized investment and wealth management services, seamlessly integrating financial experiences into daily life.Diversified Investment ProductsAt the opening ceremony, Neo revealed that uSMART Securities has recently obtained a futures trading license and is preparing to launch futures trading services by mid-year. Upon launch, clients will be able to trade futures, including index futures, commodity futures, and currency futures via the uSMART platform. This expansion provides investors with a more comprehensive range of investment products covering long-term, medium-term, and short-term investments, as well as low, medium, and high expected returns, catering to diverse client needs.Futures services will be fully integrated into the existing uSMART APP trading platform, allowing clients to trade US and Hong Kong stocks, futures, ETFs, funds, and discretionary investment products from a single APP. This enables diversified asset allocation, risk management, and wealth enhancement services, allowing clients to utilize capital efficiently and manage investment portfolios flexibly, truly achieving "one-stop wealth management with comprehensive asset allocation."Promoting Investment Education and Enhancing Client InteractionuSMART Securities is also committed to advancing investor education, regularly hosting various online and offline investment seminars and thematic events such as wine tastings and cocktail workshops. These initiatives deepen client engagement and relationships, enhancing customer retention and loyalty.Meanwhile, a new financial channel led by stock commentator and Executive Director of Research, Mr. Dickie Wong, will officially launch next Monday (March 16). Before the market opens and midday close on every Hong Kong stock trading day, a professional team will provide you with real-time analysis of market dynamics and investment opportunity. uSMART Securities aims to foster closer interaction, helping clients refine their practical skills, optimize investment decisions, and build a more comprehensive platform for learning and practice.Expanding Team SizeIn line with rapid business growth, uSMART Securities is actively advancing local talent recruitment and training. The company expects to increase its workforce by 30% over the next two years across areas including branch operations, product design, wealth management, compliance and risk control, and marketing operations. This expansion aims to enhance team scale and professional capabilities, driving steady business growth.Looking ahead, uSMART Securities will continue to optimize trading experiences and strengthen synergies between offline service points and community activities, further solidifying its leading position in financial technology. By combining innovative technology with community networks, the company strives to provide more convenient and personalized wealth management services for investors of all ages and experience levels, promoting the popularization and intelligent development of Hong Kong's financial ecosystem.^”No.1 Hong Kong Funded Fintech Brokerage" is based on TradeGo Cloud data, with uSMART Securities ranking first in monthly transaction volume among local Hong Kong-funded internet brokers for over a year as of February 2026.About uSMART:uSMART Securities is a leading Hong Kong Funded Fintech Brokerage founded in 2018. Over the past eight years, it has pioneered the fusion of technology and finance, offering stocks trading, asset management, and wealth management solutions. Its proprietary platforms, uSMART HK APP and uSMART SG APP, operated by uSMART Securities (Hong Kong) and uSMART Securities (Singapore) respectively. It supports investments in Hong Kong stocks, US stocks, A-shares (via Shanghai and Shenzhen Stock Connect), Singapore Stocks, Japan Stocks, UK Stocks, US options, ETFs, Funds, Bonds, Asset Management, Structured Notes, Futures, Crypto, Precious Metals, Gold, and forex. Furthermore, uSMART is equipped with a highly professional research and asset management team that offers asset management, wealth management, securities brokerage, institutional business, LPF services, and investment banking, dedicated to serving ultra-high-net-worth individuals and families, corporations, investment institutions, fund companies, and other brokerage firms with comprehensive asset management solutions.For details please visit: https://hk.usmartglobal.comFor any media queries, please contact:Carrie Wong9788 4665carriewong@usmart.hk Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月13日 - (亞太商訊 via SeaPRwire.com) - uSMART盈立證券有限公司（下稱「盈立證券」或「本公司」）欣然宣佈，第九及第十間實體服務中心正式進駐大圍及屯門，短短一年內，盈立證券全港服務網絡已增至12間服務中心，超越全行，積極實踐「線上 x 線下」（O2O）社區金融策略，鞏固港資科技券商No.1^地位，進一步擴大品牌影響力。推動社區金融服務普及化屯門分行今日舉行簡單而隆重的開幕典禮，標誌該分行正式投入服務，為本公司的發展里程寫下嶄新一頁。盈立證券執行董事李建翰先生 (Neo) 表示：「大圍及屯門分行的開業，是我們心繫本地社區，持續推動社區化服務的重要戰略性部署。我們不僅追求網絡覆蓋率，更重視與社區的連結，貫徹『以客為本』的理念，拉近與居民的距離，朝『全港無縫覆蓋』的目標邁進。」(左起︰盈立證券業務拓展經理林向尊先生、盈立證券研究部執行董事黃德几先生、盈立證券執行董事兼機構業務負責人李建翰先生、盈立證券香港市場部總監黃曉霖小姐及盈立證券業務拓展總監鄧永麟先生)(左起︰盈立證券業務拓展經理林向尊先生、盈立證券研究部執行董事黃德几先生、盈立證券執行董事兼機構業務負責人李建翰先生、盈立證券香港市場部總監黃曉霖小姐及盈立證券業務拓展總監鄧永麟先生)全港18區服務全覆蓋為加速實現『全港最多服務中心的科技券商』的目標，盈立證券將於第二季在核心地區 ─ 啟德及旺角開設分行，並積極物色商場期間限定店及參與各類展會攤位，希望透過多渠道接觸不同地區客戶，藉此進一步完善地區性佈置，讓全港18區市民皆可輕鬆獲取專業、個性化的投資理財服務，把金融體驗融入日常生活。」投資產品多元化Neo在開幕典禮上透露，盈立證券早前更取得期貨交易牌照，並正籌備於年中正式推出相關期貨交易業務。屆時客戶可透過uSMART平台進行期貨交易，涵蓋指數期貨、商品期貨及外匯期貨等，為投資者提供更全面的投資產品，長、中、短線投資以及低、中、高預期回報俱備，滿足不同客戶的需求。期貨業務將全面整合至現有的 uSMART APP交易平台，客戶可使用同一個APP買賣美港股、期貨、ETF、基金及全權委託投資產品等，即可享受多元資產配置、風險管理及財富增值服務，高效地運用資金，靈活地管理投資組合，真正實現「一站式理財．全方位佈局」。推動投資教育 強化客戶互動體驗盈立證券對推動投資者教育亦不遺餘力，定期舉辦不同類型的線上及線下的投資講座，及主題活動，如葡萄酒品鑑會及雞尾酒工作坊，深化與客戶的互動與關係，提升客戶黏度，增加客戶忠誠度。同時，由資深股評人兼研究部執行董事黃德几先生（Dickie）親自帶領的全新財經台，將於下周一（3月16日）強勢啟播，每個港股交易日的早上開市及中午收市前，由專業團隊為您即時剖析市場動態與投資機遇。盈立證券期望透過更緊密的互動，協助客戶精進實戰技巧、優化投資決策，打造更完善的學習與實踐平台。擴大團隊規模 配合業務高速發展，盈立證券正積極推進本地人才招募與培訓，預計未來兩年職位數量將增加30%，涵蓋前線分行、產品設計、財富管理、合規風控及市場營運等範疇，全面擴大團隊的規模及專業能力，推動業務穩健成長。 展望未來，盈立證券將持續優化交易體驗，並加強線下網點與社區活動的協同效應，進一步鞏固在金融科技領域的領先地位；同時結合創新科技與社區網絡，為不同年齡及資歷的投資者提供更便捷、更具溫度的理財服務，推動本地金融生態朝普及化及智能化發展。^「港資科技券商No.1」是取自捷利金融雲截至2026年2月為止連續超過一年數據， uSMART盈立證券為香港本地港資互聯網券商月成交總額排行第1。關於uSMART盈立證券：盈立證券 是一間領先科技港資券商，成立於2018年，8年來憑藉卓越的戰略規劃和創新能力，致力於將科技與金融深度融合，業務範圍涵蓋證券、資產管理、財富管理等領域，為全球投資者獨家研發了金融證券交易平台 uSMART HK APP和 uSMART SG APP，分別由盈立證券（香港）和盈立證券（新加坡）提供服務。集團APP 支持港股、美股、A股（滬深港通）、新加坡股票、日本股票、英國股票、美股期權、ETF、基金、債券、資管、結構化票據、期貨、加密貨幣、貴金屬、黃金和外匯等多元化的投資交易服務，此外更為超高淨值個人與家族、企業提供度身訂制服務，打造全方位綜合性資產管理解決方案。詳情可瀏覽 https://hk.usmartglobal.com傳媒查詢：黃曉霖 Carrie Wong9788 4665carriewong@usmart.hk Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SHENZHEN, CHINA, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - On 12 March 2026, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health, which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) has its innovative prescription medicine ruxolitinib phosphate cream (Lumirix®) (the “Product”, marketed as Opzelura® in the U.S., Europe and Canada) recorded the initial prescriptions for vitiligo patients across 30 provincial-level regions. The prescriptions cover approximately a thousand influential public and private medical institutions in the field of skin health and disease management, including Huashan Hospital, Fudan University, Shanghai Skin Disease Hospital, Dermatology Hospital of Southern Medical University, Second People's Hospital of Chengdu, The First Bethune Hospital of Jilin University, The Second Xiangya Hospital of Central South University, United Family Healthcare Group, among others*. Meanwhile, the Product has become concurrently accessible via over 1,300 offline drugstores as well as JD.com e-commerce platform. *Hospital rankings are listed in no particular order.As the first topical JAK inhibitor approved in China for the treatment of vitiligo, ruxolitinib phosphate cream has officially launched its large-scale clinical application today, marking a breakthrough in China’s vitiligo treatment landscape and ushering in a new era of precision targeted therapy for vitiligo. Supported by safety and efficacy fully demonstrated in clinical studies, the Product is expected to bring new hope for repigmentation to millions of vitiligo patients.The rapid commercialization progress of ruxolitinib phosphate cream underscores strong product operation capabilities of CMS (including Dermavon), while also reflecting the robust supports from China’s regulatory reforms in accelerating patient access to clinically urgently needed innovative drugs. Benefiting from the integrated healthcare ecosystem of the Hainan Free Trade Port and the “Urgently Needed Imported Drugs for Clinical Use” policy, the Product initiated pilot clinical use in August 2023 at Boao Super Hospital within the Boao Lecheng International Medical Tourism Pilot Zone. Pilot usage subsequently expanded to designated medical institutions across the Guangdong–Hong Kong–Macao Greater Bay Area, Beijing-Tianjin region and other regions. In accordance with the relevant regulations of China’s real-world data application pilot project, as well as supported by the Hainan Provincial Medical Products Administration and the Administration of the Boao Lecheng International Medical Tourism Pilot Zone, the Product has accumulated real-world clinical data in China under pilot application, significantly accelerating its clinical, registration and approval timelines. The Product received its Drug Registration Certificate on January 30, 2026 (approval date: January 27, 2026).Following its approval, in less than 1.5 months (including the Chinese New Year holiday), the initial prescriptions for ruxolitinib phosphate cream have been issued across multiple regions and hospitals, reflecting the highly efficient collaboration and concerted efforts among CMS teams, regulatory authorities and business partners. With robust support from the cross-departmental coordination mechanism of the Beijing Daxing Airport Economic Zone Joint Administrative Committee, once import conditions were met, the Product completed customs clearance approval, sampling and related customs procedures within 24 hours, and obtained the drug testing report within 7 working days, representing efficient execution and acceleration for the innovative drugs in China. During this process, the Beijing Municipal Medical Products Administration proactively provided end-to-end policy guidance; the government service center has efficiently completed customs clearance filing; the Beijing Institute for Drug Control has conducted methodological pre-testing to accelerate timelines for innovative drug, and continuous worked during the Chinese Spring Festival; and Daxing Airport Customs provided specialized pre-guidance on declaration and swiftly completed customs review and release. Through parallel workflows and coordinated execution, all parties collectively pressed the “fast-forward button” for the Product’s commercialization, helping this urgently needed innovative therapy reach patients faster.As the Product enters the large-scale clinical application stage, it is expected to further strengthen Dermavon’s comprehensive dermatology solutions and brand value. Building on its leadership in skin health, Dermavon will continue to improve accessibility of ruxolitinib phosphate cream to benefit more vitiligo patients and steadfastly safeguard public skin health through innovation.About VitiligoVitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. The discolored areas usually get bigger with time and the condition could influence skin on any part of the patients’ body. Vitiligo usually affects the appearance of patients, especially on exposed areas such as the face and neck. According to a study that involved over 1,000 diagnosed vitiligo patients, over 45% of patients have facial involvement, and over 20% of patients have neck involvement[1].The obvious presence of white patches may make patients feel that their appearance has been compromised, which in turn materially affects their social life, and is associated with a significantly higher incidence of mental health disorders; accordingly, there is an urgent need for effective treatment options for vitiligo[2].It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[1]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. Ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance.More Information About Ruxolitinib Phosphate CreamRuxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is the first and only drug approved for the repigmentation of non-segmental vitiligo by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)[3,4]. In the U.S., the Product is indicated for the topical treatment of nonsegmental vitiligo in adult and pediatric patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis (AD) in non-immunocompromised adult and pediatric patients aged 2 years and older whose disease is not well controlled with topical prescription therapies, or when those therapies are not advisable. In Europe, ruxolitinib phosphate cream is approved for the topical treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age. In China, besides vitiligo indication, the product’s NDA for the treatment of mild-to-moderate AD in adults and pediatric patients aged 2 years and older is also under regulatory review, which has been included in the Priority Review List and is expected to accelerate the Product’s AD review process for marketing approval.The Group, through the subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside of Mainland China to the Group (excluding Dermavon and its subsidiary).Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream (excluding territories in which exclusive rights have already been licensed), marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference:1. China Insights Consultancy’s industrial report 2. Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis[J]. Journal of the European Academy of Dermatology and Venereology, 2018,32(8):1343-1351. DOI:10.1111/jdv.14739. 3. The U.S. FDA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream4. The EMA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurarCMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) – 12 March 2026, Guoquan Food (Shanghai) Co., Ltd. ("Guoquan" or the "Company"; stock code: 2517.HK), a leading one-stop home meal products brand in China, announced its annual results for the year ended 31 December 2025, which have been reviewed by the Audit Committee of the Board.Adhering to the strategic positioning of "community central kitchen" in 2025, the Company successfully established a holistic instant retail store network through a multi-channel, multi-scenario omni-channel layout and the deep integration of online and offline operating models. The Company continuously delved into consumers' demand, developed and iterated a diverse suite of product portfolios, deepened refined store operation and management, and strengthened the construction of a membership ecosystem, effectively enhancing store operational efficiency and market competitiveness. Concurrently, the Company continued to deepen its industrial layout and promote the integrated closed-loop construction of "production, supply and marketing", achieving stable development throughout the year.For the year ended 31 December 2025, the Company's revenue amounted to RMB7,810.0 million, representing a year-on-year increase of 20.7%. Gross profit reached RMB1,686.6 million, a year-on-year increase of 19.0%. Net profit was RMB453.9 million, a significant year-on-year increase of 88.2%. Core operating profit (adjusted for non-recurring items such as gains or losses on fair value changes on unlisted convertible redeemable preferred shares and donations for fire rescue in Tai Po, Hong Kong) was RMB460.7 million, representing a year-on-year increase of 48.2%. Basic and diluted earnings per share were RMB0.1630, a substantial year-on-year increase of 93.8%.Continuously Strengthening Omni-channel Instant Retail: Offline Expansion and Online Engagement Drive GrowthAs of 31 December 2025, the Company's total number of stores nationwide reached 11,566, a net increase of 1,416 stores from 10,150 as at the end of 2024, covering 31 provinces, autonomous regions and municipalities. In terms of regional store layout, the Company achieved a net increase of 1,004 township-level stores in 2025. Addressing the consumption characteristics and needs of township markets, the Company developed differentiated product structures and store displays, accurately aligning with consumer demands in lower-tier markets and further enhancing township market penetration. Concurrently, the Company continued to deploy smart retail scenarios in mid-to-high-tier markets, completing the intelligent and unmanned transformation and upgrade of over 3,000 retail stores in 2025, achieving synergistic development between lower-tier and mid-to-high-tier markets.To empower franchisees, facilitate their sales growth, and further expand consumer reach while offering a more flexible shopping experience, the Company continuously provides support and guidance to franchisees in core areas such as store operations and business development. Leveraging the Company's Guoquan APP, WeChat mini-program, third-party food delivery platforms and social commerce platforms (such as Douyin), a multi-level online sales network has been established. In 2025, the Company achieved over 9.41 billion impressions on platforms through its multi-level Douyin accounts matrix. Stores generated GMV of RMB1.49 billion via the Douyin channel, representing a year-on-year increase of 75.3%.Membership Ecosystem Continuously Improved; Product Portfolio Enhances in Scenarization and RichnessIn 2025, the operation of the Guoquan membership program yielded significant results, further releasing the value of the membership ecosystem. During the Reporting Period, the number of the Company's registered members reached approximately 64.9 million, a year-on-year increase of 57.1%, demonstrating rapid expansion of the membership base. The prepaid card business also achieved stable growth, with the value stored in prepaid cards amounting to approximately RMB1.2 billion during the Reporting Period, a year-on-year increase of 22.3%. This indicates continuously improving member stickiness and consumption contribution, forging a closer connection with consumers.Relying on its substantial membership base, the Company persistently pursues innovation in its product offerings, consistently upholding the business philosophy of providing consumers with "tasty, convenient and value-for-money" products. It continuously enriches its product portfolio and iterates new products to comprehensively meet consumers' diverse dining needs. As of 31 December 2025, the Company had introduced 282 new SKUs of hot pot and barbecue products. It created multiple scenarized meal suites such as the "Barbecue Camping Container Set", "Crayfish Feast Set", and "Six Popular Hot Pot Sets", achieving deep integration of products and consumption scenarios. Furthermore, the Company expanded its product categories within the drinks and beverage consumption scenario, launching products such as NFC fruit juices, craft beer, and flavored tea beverages. This continuously enhances the richness and diversification of the product matrix, further perfecting the one-stop meal products supply system.Deepening Industrial Layout; Strengthening Digitalized Supply Chain ControlGuoquan continues to promote the integrated closed-loop construction of "production, supply and marketing". Adopting a "one-product-one-factory" strategy, it further deepens the breadth and depth of its industrial layout, providing solid production capacity support for business development. As of 31 December 2025, the Company possessed seven food ingredient production plants, covering core categories such as condiments, meatballs, paste and aquatic products, and beef products, forming a comprehensive and well-defined production capacity matrix. Concurrently, the construction of the Company's food production base in Danzhou, Hainan Province, officially commenced. This base will further expand its geographical coverage, optimize the supply chain's radiation radius, and strengthen the national production capacity layout and logistics reach.This solid industrial foundation continuously improves the operational efficiency of the digitalized supply chain. Based on the supply chain system operating from factory to central warehouse and to retail stores, the Company can monitor supply and demand dynamics from the procurement end to the store end, and closely manage inventory levels, thereby achieving efficient management of the entire supply chain. As of 31 December 2025, the Company had deployed 20 digitalized central warehouses across China, achieving swift product circulation through digital stock and barcode management. Simultaneously, the digitalization of the supply chain covering core segments such as production, procurement, warehousing, and logistics allows for precise monitoring of supply-demand dynamics and inventory levels, ensuring the timely supply of products to stores in the Chinese mainland. This comprehensively enhances the overall operational efficiency of the supply chain, solidifying core barriers in cost control and quality assurance.Six Core Strategic Directions: Continuously Advancing Business UpgradesIn 2026, Guoquan targets that the total number of stores will exceed 14,500, representing a net increase of over 2,934 stores, with an estimated store closure rate of less than 4%. It targets high-single-digit growth in store efficiency, and the number of registered members is targeted to exceed 95 million. The Company targets that the growth rate of core operating profit will be significantly higher than that of its revenue.First, Fully expand the sales network with four stores jointly advancing with concerted efforts. Guoquan will continue to build a multi-level sales network, accelerate the expansion of large stores in townships, practice the philosophy of "food equality", and precisely meet the consumption needs of residents in county and township markets. Concurrently, it will explore innovative store formats and upgrade the franchisee management system to build a symbiotic and mutually beneficial franchise ecosystem.Second, Deepen the strategy of community central kitchen to expand community consumption scenarios. The Company will focus on creating food retail solutions for "four meals a day", continuously diversifying its product categories and building a more competitive product matrix to achieve organic sales growth while further consolidating its advantages in lower-tier market layout.Third, Deepen membership operation and IP to advance the community brand project. The Company will continue to advance refined membership operation, deeply integrate media resources such as popular TV commercials, offline community advertising and social media and e-commerce platforms (such as Douyin) to expand its membership base, and improve the membership rights system to enhance member loyalty and stickiness. Furthermore, it will further deepen the operation of its brand IP image "Guobao" to strengthen brand value and emotional resonance with consumers.Fourth, AI big data empower stores to innovate smart retail scenarios. By integrating Internet of Things, big data, and AI technology, the Company will drive the smart operation of stores with data. It will promote the in-depth integration of the Guoquan stir-fry business format with smart cooking machines, accurately analyze consumers' dining habits, optimize dish parameters and cooking procedures for smart cooking machines, realize the standardized production of stir-fry dishes, and optimize the consumer experience.Fifth, Continue to promote the industrial layout and strengthen the advantage of one-product-one-factory. Adhering to the "one-product-one-factory" strategy, Guoquan will further integrate upstream resources domestically and internationally, accelerate the construction of the food production base in Danzhou, Hainan Province, increase R&D investment, and launch more product portfolios with a high quality-price ratio.Sixth, Develop overseas markets in phases to deliver the good taste of China. Guoquan plans to explore and establish a presence in overseas regional markets in a phased manner to unlock long-term growth potential. Leveraging its core competitiveness, it will steadily advance its overseas market exploration. It also plans to take the lead in opening stores in Hong Kong Special Administrative Region, China to accumulate and gather operational experience, gradually achieving overseas product sales and enhancing global brand visibility.About Guoquan Food (Shanghai) CO., LTD. (2517.HK):Guoquan Food (Shanghai) Co., Ltd. (“Guoquan”; Stock Code: 2517.HK) is the leading one-stop home meal products brand in China, offering a variety of ready-to-eat, ready-to-heat, ready-to-cook and prepared ingredients, with a focus on at-home hotpot and barbecue products. Leveraging Company’s robust supply chain capabilities, a strategic industrial layout with self-owned factories, a nationwide network of around 10,000 instant retail stores, and a carefully curated product portfolio, Company offer a variety of home meal products solution under the “Guoquan Shihui” brand, catering to different dining scenarios.This press release is issued by EverBloom (HK) Communications Consultants Group Limited on behalf of Guoquan Food (Shanghai) Co., Ltd. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

深圳, 2026年3月13日 - (亞太商訊 via SeaPRwire.com) - 2026年3月12日，康哲藥業控股有限公司 （「康哲藥業」）欣然宣佈，旗下德鎂醫藥有限公司（「德鎂醫藥」，專業聚焦皮膚健康的創新型醫藥企業，正申請於香港聯合交易所有限公司主板獨立上市），其創新處方藥磷酸蘆可替尼乳膏（百盧妥(R)）（「產品」，在美國、歐洲及加拿大以Opzelura(R)的名稱銷售）在全國30個省級行政區為白癜風患者開出首批處方，覆蓋包括復旦大學附屬華山醫院、上海市皮膚病醫院、南方醫科大學皮膚病醫院、成都市第二人民醫院、吉林大學白求恩第一醫院、中南大學湘雅二醫院、和睦家醫療集團等千家在皮膚健康及疾病管理領域具有影響力的公立及私立醫療機構*，並實現超1,300家線下藥店以及京東電商平臺同步可及。*醫院排名不分先後磷酸蘆可替尼乳膏為中國批准的首款用於白癜風治療的外用JAK抑制劑，今日正式拉開產品規模化臨床應用的序幕，標誌著我國白癜風治療領域實現突破性進展，邁入精准靶向治療的全新時代，產品將以經過臨床充分驗證的安全和有效性，點亮千萬白癜風患者複色希望。磷酸蘆可替尼乳膏的跨越式商業化進程，不僅彰顯了康哲藥業卓越的產品運營能力，更充分體現了國家藥政改革對臨床亟需創新藥加速可及的有力支持。受益於海南自貿港醫療健康產業整合性優勢，以及 「臨床急需進口」 政策，2023年8月，產品率先在海南博鼇樂城國際醫療旅遊先行區博鼇超級醫院啟動臨床應用，隨後試點應用逐步擴展至粵港澳大灣區、京津等區域指定醫療機構。在我國藥品真實世界數據應用試點有關程序，以及海南省藥品監督管理局與海南博鼇樂城國際醫療旅遊先行區管理局的支持下，產品通過「先行先試」臨床應用積累中國真實環境的診療數據，大大提速產品臨床、註冊和獲批上市進程，並成功於2026年1月30日取得《藥品註冊證書》（批准日期2026年1月27日）。獲批以來，僅耗時不到1.5個月（含春節假期），磷酸蘆可替尼乳膏便實現全國多地、多醫院首批處方集中落地，這亦是康哲藥業各部門、相關監管部門及合作夥伴高效聯動、共同努力的成果。在北京大興臨空區聯合管委會跨部門合作機制的有力保障下，產品具備進口條件後24小時內即完成了藥品通關審批、藥品抽樣及海關程序，並於7個工作日內取得藥品檢驗報告，全程跑出了高效務實的「中國創新藥加速度」。在此過程中，北京市藥監局主動開展商業規模批次政策的全流程指導，政務中心高效完成通關備案；北京市藥品檢驗研究院則通過前置方法學預檢驗、開闢創新藥專項通道，並在春節期間持續作業，全力確保檢驗進度高效推進；大興機場海關則提前對藥品申報要素進行專項指導，快速完成報關審核和藥品放行工作。各方協同、流程並聯，合力為磷酸蘆可替尼乳膏上市按下「快進鍵」，助力該臨床急需創新藥惠及廣大患者。隨著產品進入規模化臨床應用階段，將進一步強化德鎂醫藥皮膚疾病綜合解決方案及品牌價值。德鎂醫藥依託在皮膚健康領域的領先地位，將持續推進磷酸蘆可替尼乳膏使更多白癜風患者獲益，以創新之力堅定守護民眾皮膚健康。關於白癜風白癜風是一種慢性自身免疫性疾病，其特徵是皮膚色素脫失，其發病原因為產生色素的細胞即黑素細胞的缺失。脫色區域通常會隨著時間的推移而擴大，且該病症可能影響患者身體任何部位的皮膚，影響患者的容貌，尤其是面部、頸部等顯眼部位。根據一項對1,000多名已確診白癜風患者進行的研究，超過45%的患者面部受累，超過20%的患者頸部受累[1]。白色斑塊的明顯存在可能會讓患者認為自身的形象受到損害，進而嚴重影響其社會活動，精神疾病發病率顯著增加，因此白癜風的治療需求非常迫切[2]。據估算，中國約有1,030萬人患有白癜風，其中約820萬人患有非節段型白癜風[1]。現有療法，如外用糖皮質激素（TCS）及外用鈣調神經磷酸酶抑制劑（TCIs）存在臨床缺陷，長期用藥有不良反應或療效有限。磷酸蘆可替尼乳膏成功填補了白癜風靶向藥物治療的空白，具有重大標誌性意義。關於磷酸蘆可替尼乳膏的更多資訊磷酸蘆可替尼乳膏（Opzelura(R)）是Incyte開發的選擇性JAK1/JAK2抑制劑蘆可替尼製成的一種創新型乳膏，是經美國食品藥品監督管理局（FDA）及歐洲藥品管理局（EMA）批准的首款也是唯一一款用於非節段型白癜風複色的藥物[3,4]。在美國，產品獲批用於局部治療成人及12歲及以上兒童患者的非節段型白癜風；及其他外用藥控制不佳或不建議使用時，非免疫功能受損的2歲及以上兒童和成人輕中度特應性皮炎的局部短期和非持續性慢性治療。在歐洲，磷酸蘆可替尼乳膏被批准用於局部治療成人及12歲及以上青少年伴面部受累的非節段型白癜風。在中國，除白癜風適應症外，產品2歲及以上兒童和成人輕中度特應性皮炎（AD）適應症亦處於NDA審評階段， 且該項NDA已獲納入優先審評品種名單，有望加快產品AD適應症上市審評進程。康哲藥業於2022年12月2日，通過德鎂醫藥的附屬公司與Incyte就磷酸蘆可替尼乳膏訂立合作和許可協議（「許可協議」），獲得在中國大陸、香港特別行政區、澳門特別行政區、臺灣地區及東南亞十一國（「區域」）研發、註冊及商業化產品的獨家許可權利，以及在區域內生產產品的非獨家許可權利。德鎂醫藥的附屬公司已將磷酸蘆可替尼乳膏除中國大陸外的其他區域的相關權利再許可予康哲藥業（不包括德鎂醫藥及其附屬公司）。Incyte擁有磷酸蘆可替尼乳膏全球開發和商業化權利（已獨佔許可區域除外），在美國及歐洲以Opzelura(R)的名稱銷售。Opzelura(R)和Opzelura(R)標識是Incyte的註冊商標。關於康哲藥業康哲藥業是一家鏈接醫藥創新與商業化，把控產品全生命週期管理的開放式平臺型企業，致力於提供有競爭力的產品和服務，滿足尚未滿足的醫療需求。康哲藥業專注於全球首創（FIC）及同類最優（BIC）的創新產品，並高效推進創新產品臨床研究開發和商業化進程，賦能科研成果向診療實踐的持續轉化，造福患者。康哲藥業聚焦專科領域，擁有被驗證的商業化能力，廣泛的渠道覆蓋和多疾病領域專家資源，核心在售產品已獲領先的學術與市場地位。康哲藥業圍繞優勢專科領域不斷縱深發展，以鞏固心腎代謝/消化/眼科/皮膚健康業務競爭力，帶來專科規模效率，其中皮膚健康業務（德鎂醫藥）已成為其細分領域的龍頭企業，並擬於聯交所獨立上市。同時，康哲藥業持續推動研產銷全產業鏈在東南亞及中東區域運營發展，以獲取新興市場的增量，助力集團實現高質量可持續發展。參考文獻/資料1.數據來自灼識諮詢報告2.Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis[J]. Journal of the European Academy of Dermatology and Venereology, 2018,32(8):1343-1351. DOI:10.1111/jdv.14739.3.FDA批准信息可在Incyte官網查詢，網址：https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream4.EMA批准信息可在Incyte官網查詢，網址：https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar康哲藥業免責與前瞻性聲明本新聞無意向您做任何產品的推廣，非廣告用途。本新聞不對任何藥品和-醫療器械和/或適應症作推薦。若您想瞭解具體疾病診療資訊，請遵從醫生或其他醫療衛生專業人士的意見或指導。醫療衛生專業人士作出的任何與治療有關的決定應根據患者的具體情況並遵照藥品說明書。由康哲藥業編制的此新聞不構成購買或認購任何證券的任何要約或邀請，不形成任何合約或任何其他約束性承諾的依據或加以依賴。本新聞由康哲藥業根據其認為可靠之資料及數據編制，但康哲藥業並無進行任何說明或保證、明述或暗示，或其他表述，對本新聞內容的真實性、準確性、完整性、公平性及合理性不應加以依賴。本新聞中討論的若干事宜可能包含涉及康哲藥業的市場機會及業務前景的陳述，該等陳述分別或統稱為前瞻性聲明。該等前瞻性聲明並非對未來表現的保證，存在已知及未知的風險、不明朗性及難以預知的假設。康哲藥業並不採納本新聞包含的第三方所做的任何前瞻性聲明及預測，康哲藥業對該等第三方聲明及預測不承擔責任。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

From a joyful Raya musical to new and improved festive recipes, Spritzer Sparkling inspires Malaysians to embrace fresh new ideas alongside tradition to elevate their Raya celebrationsSpritzer Sparkling’s 2026 Raya musical brand film “Samting-Samting”, stars Fimie Don and Wani Kayrie as a married couple, and Elliza Razak as Mak Ngah.TAIPING, Malaysia, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - Hari Raya Aidilfitri in the month of Syawal is a cherished time of celebration and time-honoured family traditions, with the kitchen often becoming the heart of the festivities. As families balik kampung and fill their homes with the joy and warmth of festive cooking this year, Spritzer Sparkling invites Malaysians to celebrate Raya with a modern twist through its ‘Serikan Raya, Sparkling-kan Suasana’ campaign, showcasing the versatility of the product in boosting the creativity and flair of beloved Raya dishes.For the first time, Spritzer Sparkling is expanding beyond its well-loved role as a beverage mixer with a fresh take on festive cooking through the multipurpose use of its naturally refreshing sparkling water in your favourite recipes. Spritzer Sparkling transforms five traditional must-have Raya dishes into festive showstoppers, bringing a new dimension of taste with its lively carbonation enhancing the texture, crispiness, and tenderness of the dishes. These favourites include Cucur Udang Crispy, Rendang Tok Melting, and Roti Jala with Kari Ayam, alongside refreshing drinks like Bunga Longan Sparkling and Limau Selasih Pudina Sparkling.This Raya, add a little ‘Samting-Samting’ extra to your recipes for an exciting new twist on your favourite festive dishes with Spritzer SparklingEach recipe showcases how the natural bubbles from Spritzer Sparkling help create lighter, crispier batters for a satisfying crunch and more tender, flavourful meats without changing the essence of the dishes. Whether it is giving your cucur udang a delightful crisp or tenderising your rendang meat and shortening the braising time, Spritzer Sparkling makes these traditional favourites even more enjoyable in simple, effortless ways.Shiao Chan, Head of Marketing at Spritzer, said, “Hari Raya Aidilfitri is a celebration deeply rooted in family traditions where food plays a central role in bringing people together. Through ‘Serikan Raya, Sparkling-kan Suasana’, we wanted to show Malaysians that tradition and heritage can co-exist and even be preserved through innovation and new perspectives. Spritzer Sparkling is not just a refreshing beverage for every season, but also a multi-faceted ingredient that can enhance festive dishes and drinks, creating memorable family moments in the kitchen and around the dining table.”A Musical Aidilfitri AwaitsBringing the Raya story to life is Spritzer’s musical film titled ‘Samting-Samting’, starring Fimie Don, Wani Kayrie and Elliza Razak. As the official Spritzer Sparkling brand ambassadors for Raya 2026, Fimie Don and Wani Kayrie, play a modern newlywed couple returning to the husband’s kampung for their first Raya together in the film that blends comedy, drama and music in an irresistibly Malaysian narrative.The young wife, Alia, takes on the kitchen with confidence, using her own modern approach to classic family dishes, prepared using her secret ingredient: Spritzer Sparkling. Mak Ngah, the family’s long-standing culinary matriarch, feels her role is being challenged and grows increasingly suspicious about Alia’s unusually delicious cooking, suspecting “Samting-Samting” is amiss. The story humorously unravels the “secret” behind Alia’s crowd-pleasing flavours, capturing family dynamics and celebrating new perspectives, shared discovery, and the warmth of intergenerational bonding.Home-cooks excited to try this new twist to classic recipes can check out the recipes for the featured dishes and beverages using Spritzer Sparkling as a game-changing ingredient on Spritzer’s Raya microsite here.Spritzer’s 2026 Raya campaign celebrates family traditions, playful generational dynamics in the kitchen, and creative festive cooking with Spritzer Sparkling.Also available on the website are the musical film, promotional details, meet-and-greet information with Fimie Don and Wani Kayrie, as well as gift-with-purchase promotions available at participating outlets nationwide.About SpritzerEstablished in 1989, Spritzer is a leading Malaysian bottled water brand, sourcing natural mineral water from a protected 430-acre rainforest in Taiping. Naturally filtered through underground rock layers for over 15 years, our water is enriched with essential minerals like Silica, known to support skin, bones, hair, and nails.Combining smart manufacturing with sustainable practices, Spritzer ensures every bottle meets the highest quality and safety standards. Our packaging is 100% recyclable and made from recycled materials, reflecting our commitment to environmental stewardship and a circular economy.Tested annually by SIRIM to be free from microplastics, Spritzer offers consumers trusted, natural hydration. Our diverse product range includes Natural Mineral Water, Original and Flavoured Sparkling Water, Distilled Water, and Fruit-Flavoured Beverages—crafted to suit every lifestyle and occasion.With a clear vision to become a fully circular brand by 2030, Spritzer leads the industry in innovation, quality, and sustainability.Spritzer — where nature, innovation, and sustainability come together in every bottleFor more information, visit www.spritzer.com.myFor media inquiries please contact:Farah ShahrulAssociate Consultant, Narro CommunicationsE: farah@narrocomms.comWinnie ChinHead of Public Relations, Spritzer BhdE: winniecgl@spritzer.com.my Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月13日 - (亞太商訊 via SeaPRwire.com) - 3月12日，中國領先的一站式在家吃飯餐食產品品牌鍋圈食品（上海）股份有限公司（簡稱「鍋圈」或「公司」，股票代號：2517.HK）公佈截至2025年12月31日止十二個月經董事會審核委員會審閱之全年業績。2025年，鍋圈堅持「社區央廚」的戰略定位，通過多渠道、多場景的全域佈局，深度融合線上線下運營模式，成功構建全方位的即時零售門店網路。公司持續深耕消費者需求，不斷開發並迭代多樣化套餐產品組合，深化門店精細化運營管理，健全會員生態體系建設，有效提升了門店經營效能與市場競爭力。與此同時，公司持續深化產業端佈局，推動「產供銷」一體化閉環建設，實現全年穩健發展。截至2025年12月31日止年度，鍋圈收入為人民幣7,810.0百萬元，同比增長20.7%；毛利為人民幣1,686.6百萬元，同比增長19.0%；淨利潤為人民幣453.9百萬元，同比增長88.2%；核心經營利潤（經調整後非上市可轉換可贖回優先股公允價值變動損益、香港大埔火災救援捐贈等一次性因素後）為人民幣460.7百萬元，同比增長48.2%；每股基本及攤薄盈利為人民幣0.1630元，同比增長93.8%。持續夯實全渠道即時零售 線下擴張+線上聯動驅動增長截至2025年12月31日，鍋圈全國門店總數達11,566家，較2024年末的10,150家淨增1,416家，全面覆蓋全國31個省、自治區及直轄市。在門店區域佈局上，2025年公司淨新增1,004家鄉鎮門店，並針對鄉鎮市場消費特點與需求，打造差異化產品結構與門店陳列，實現與下沉市場消費需求的精准匹配，進一步提升鄉鎮市場滲透率。與此同時，公司持續佈局中高線市場智慧化零售場景，2025年完成超三千家零售門店的智慧化、無人化改造升級，實現下沉市場與中高線市場的協同發展。為賦能加盟商、促進其銷售增長，並進一步擴大消費者覆蓋範圍、提供更靈活的購物體驗，公司持續在門店運營、業務發展等核心環節為加盟商提供支持，依托鍋圈APP、微信小程序、第三方外賣平台及社交商務平台（如抖音），構建多層次的線上銷售網絡。2025年，公司通過多層級抖音賬號矩陣實現超94.1億次平台曝光量，門店通過抖音渠道實現GMV達14.9億元，同比增長75.3%。會員生態體系持續完善 產品矩陣場景化與豐富度雙提升2025年，鍋圈會員計劃運營成效顯著，會員生態體系價值進一步釋放。於報告期內，公司註冊會員數量達約6,490萬名，同比增長57.1%，會員規模實現快速擴張；預付卡業務同步實現穩健增長，報告期內預付卡預存金額達約人民幣12.0億元，同比上升22.3%，會員黏性與消費貢獻持續提升，與消費者的連結更為緊密。以龐大的會員基礎為依托，公司持續深耕產品端創新，始終秉持「好吃方便還不貴」的經營理念，不斷豐富產品組合並迭代新品，全方位滿足消費者多樣化用餐需求。截至2025年12月31日，公司共推出282個火鍋及燒烤類產品的新SKU，打造「燒烤露營集裝箱套餐」「小龍蝦暢享套餐」「六大國民火鍋套餐」等多款場景化套餐產品，實現產品與消費場景的深度融合。此外，公司圍繞酒水飲料消費場景進行品類拓展，推出NFC果汁、精釀啤酒、風味茶飲等產品，持續提升產品矩陣的豐富度與多元化程度，進一步完善一站式餐食產品供給體系。深化產業端佈局 強化供應鏈數字化管控鍋圈持續推動「產供銷」一體化閉環建設，通過「單品單廠」策略進一步深化產業端佈局的深度與廣度，為業務發展提供堅實的產能支撐。截至2025年12月31日，公司已擁有7個食材生產廠，覆蓋調味料、丸滑水產、牛肉等核心品類，形成品類齊全、分工明確的產能矩陣；與此同時，公司位於海南省儋州市的食品生產基地正式動工建設，未來將進一步拓寬地理覆蓋範圍，優化供應鏈輻射半徑，強化全國產能佈局與物流輻射能力。產業端的堅實基礎推動供應鏈數字化運營效率持續提升，基於從工廠到中央倉再到零售門店的供應鏈體系，公司能對從採購端到門店端的供需動態進行監控，並密切把控存貨水準，從而實現對整個供應鏈的高效管理。截至2025年12月31日，公司已佈局20個數字化中央倉庫，透過數字化存貨和條碼管理實現產品快速流通；與此同時，實現生產、採購、倉儲、物流等核心環節的供應鏈數字化，精準監控供需動態與存貨水平，保障中國內地門店產品及時供應，全面提升供應鏈整體運營效率，築牢成本管控與品質把控的核心壁壘。六大核心戰略方向 持續推進業務升級2026年，鍋圈預計門店總數超過14,500家，即淨新增門店超2,934家，預計關店率低於4%，門店店效實現高單位數增長，註冊會員數量超過95百萬名。公司預計核心經營利潤增速將明顯高於收入增速。一是，全面拓展銷售網路，四店齊發聚力共進。鍋圈將繼續打造多層級銷售網絡，加速鄉鎮大店拓展步伐，踐行「美食平權」理念，精準對接縣鄉市場居民的消費需求；與此同時，探索創新店型且升級加盟商管理體系，構建共生共贏的加盟生態。二是，深化社區央廚戰略，延展社區消費場景。公司將圍繞「一日四餐」打造餐飲零售解決方案，持續佈局多元品類，打造更具市場競爭力的產品矩陣，實現銷售規模的有機增長的同時，進一步夯實下沉市場佈局優勢。三是，深耕會員運營及IP，推進社區品牌工程。公司將持續推進會員精細化運營，深度整合知名電視廣告、線下社區廣告和社交電商平台（如抖音）等媒體資源，擴大會員規模，並完善會員權益體系，提升會員忠誠度與黏性。與此同時，公司將進一步深化品牌IP形象「鍋寶」的運營，提升品牌價值與消費者的情感連結。四是，AI大數據賦能門店，創新智慧零售場景。結合物聯網、大數據及AI技術實現門店智慧化運營，推動鍋圈小炒與智慧炒菜機深度融合，精準分析消費者餐飲習慣，優化智慧炒菜機的菜品參數與烹飪流程，實現菜品標準化製作並優化消費體驗。五是，持續推動產業佈局，強化單品單廠優勢。鍋圈堅守「單品單廠」策略，將進一步整合海內外上游資源，加快海南省儋州市食品生產基地建設，加大研發投入並推出更多高性價比產品組合。六是，海外市場分階落地，傳遞中國好味道。鍋圈計劃分階段佈局海外市場，挖掘長期增長潛力，立足核心競爭力穩步推進海外市場探索，亦計劃率先在中國香港開設門店並積累運營經驗，逐步實現產品海外銷售，提升全球品牌知名度。關於鍋圈食品（上海）股份有限公司(2517.HK)：鍋圈食品（上海）股份有限公司（股票代號：2517.HK）是中國領先的一站式在家吃飯餐食產品品牌，提供即食、即熱、即煮和即配食材，並專注於在家火鍋和燒烤產品。憑藉強大的供應鏈能力、自有工廠的產業端佈局，遍佈全國的萬家即时零售門店網絡及精心策劃的產品組合，公司使用「鍋圈食匯」品牌為消費者提供各種在家吃飯餐食產品解决方案，服務於不同的用餐場景。本新聞稿由九富（香港）財訊公關集團有限公司代表鍋圈發佈。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - March 12, 2026) - Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) ("Founders" or the "Company") announces that Lower Antino has been upgraded from Intermediate to Advanced Target status - the same internal classification* as Upper Antino - at its Antino Gold Project in southeastern Suriname (Figure 1). The upgrade follows cumulative drilling of 50 diamond drill holes including eight new holes reported here that continue to demonstrate broad, continuous gold mineralization, highlighted by 65.9 metres (m) of 1.16 grams per tonne (g/t) gold (Au) within a broader envelope of 115.0 m of 0.83 g/t Au from surface in drill hole LA046.HighlightsLower Antino upgraded to Advanced Target status with 50 drill holes released to date with an additional 10 holes pending assays and further expansion drilling underwayBest intercept to date: 65.9 m of 1.16 g/t Au within 115.0 m of 0.83 g/t Au from surface (LA046)Broad mineralized envelopes confirmed: 113.5 m of 0.34 g/t Au from surface including 30.0 m of 0.82 g/t Au (LA044)Intrusion-hosted gold mineralization intersected in all eight drill holes reported in this release; mineralization remains open along strike and at depthColin Padget, President & CEO, commented, "Lower Antino's upgrade from Intermediate to an Advanced Target - now sharing the same classification as Upper Antino - reflects consistent, broad gold mineralization across a growing number of drill holes. LA046 returning 65.9 metres of 1.16 g/t gold within a 115-metre mineralized envelope is the best intercept to date at this target and underscores the scale and continuity of the Lower Antino intrusion-hosted gold system. With gold in every hole and consistently wide intercepts, Lower Antino is emerging as a meaningful contributor to the district's overall potential. While our focus remains on exploration and expansion drilling, Lower Antino's advancement to the same classification as Upper Antino means it is expected to be considered for inclusion in any future resource estimate for the district."Lower Antino - Upgraded to Advanced TargetThe Company reports assay results from eight diamond drill holes (LA043 to LA050) at the Lower Antino target, located approximately 3.5 km east of the Upper Antino deposit (Figure 1). All eight holes intersected gold mineralization, with results highlighted by 65.9 m of 1.16 g/t Au within 115.0 m of 0.83 g/t Au in LA046 (Table 1). The 115-metre intercept in LA046 begins at surface and represents an up-dip expansion of the previously released 90.0 m of 1.02 g/t Au in LA041, confirming the continuity and growth potential of the mineralized zone.Based on cumulative drilling results, Founders has upgraded Lower Antino from Intermediate Target to Advanced Target status, ranking it on the same tier as Upper Antino in terms of overall target quality and scale potential. The upgrade reflects the demonstrated continuity of gold mineralization across numerous drill sections and identification of multiple parallel, northeast-trending mineralized zones over approximately 1.9 km of drill-defined strike length within a broader 1.5 km by 2.8 km gold-in-auger anomaly.The target is open along strike and at depth with drilling ongoing to the south and southeast at regular 100 to 200 metre steps. Overall, gold mineralization remains consistent with previous Lower Antino drill results and is hosted in intensely sericite-altered, sheared tonalite with disseminated pyrite and quartz-pyrite veining. The southernmost hole in this release (LA050), intersected 24.0 m of 0.57 g/t Au and represents approximately 200 metres of southward expansion of the mineralized system. Assay results are presented in Table 1, with drill hole locations in Table 2.Lower Antino is one of two Advanced Targets within Founders' 102,360-hectare contiguous land package, which hosts eight drill tested gold targets across the 55 km long Antino concession. The upgrade of Lower Antino adds meaningful scale to the Company's growing inventory of drill-defined gold mineralization at the district level. The Company will continue to systematically advance and upgrade high-quality targets as defined by geological criteria linked to scale and growth potential.*The Company's internal target classification system reflects drill density, demonstrated continuity of mineralization, and data sufficiency; it does not correspond to NI 43-101 resource categories.Figure 1: Antino Gold Project Property MapTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7574/288304_571962fb64ca9a3d_001full.jpgFigure 2: Lower Antino Plan MapTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7574/288304_571962fb64ca9a3d_002full.jpgFigure 3: Lower Antino cross-section through central gold trend.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7574/288304_571962fb64ca9a3d_003full.jpgTable 1: Lower Antino Drill ResultsDrillholeFrom (m)To (m)Interval (m)Au (g/t)Results from This ReleaseLA043162.00174.0012.001.56incl.167.00174.007.002.56LA0441.50115.00113.500.34incl.8.1038.1030.000.82LA0450.0020.1020.100.31and111.00124.0013.000.44LA0460.00115.00115.000.83incl.41.10107.0065.901.16LA0470.008.108.100.94and149.00156.007.000.46LA0480.0027.6027.600.22and173.00178.005.000.80LA0496.6011.104.500.21LA05047.1071.1024.000.57Previously Released Highlight ResultsLA041156.00246.0090.001.02incl.176.00178.002.0028.44LA00374.10156.0081.901.00incl.106.00132.0026.002.36LA0250.00241.00241.000.27incl.0.0086.1086.100.43LA03329.1060.0030.901.56LA02472.00122.0050.001.02LA028108.00163.0055.000.64incl.110.00117.007.002.32LA0190.0065.0065.000.49incl.44.1065.0020.901.11LA01033.6057.6024.001.23 **Intervals are down-hole depths. True widths of mineralization are estimated to be approximately 85% of the down-hole interval based on currently available results and observations. All are diamond drill holes. Average grades are calculated with un-capped gold assays, as insufficient drilling has been completed to determine capping levels for higher grade gold intercepts. Composites are calculated using a 0.10 g/t Au cut-off grade with